by Ryan Paolicelli | Feb 23, 2023
Cynthia Burzell holds a Ph.D. in Marine and Medical Microbiology, is co-Founder and CSO of Aequor, Inc., leading independent antibiofilm and antifouling research for the past fifteen years worldwide. The Global Antibiotic Research and Development Partnership (GARDP)...
by Ryan Paolicelli | Feb 23, 2023
Dr. Vasan Sambandamurthy is Senior Vice President – Strategy & Global Operations at Bugworks Research Inc – a clinical stage biopharmaceutical company that is developing novel class of broad-spectrum antibacterial agents and immunotherapies to treat patients with...
by Luka Srot | Mar 30, 2021
Marc Gitzinger is Chief Executive Officer and co-founder of BioVersys. He has over 10 years of experience in the biotech industry, having launched a university spin-off in the field of antimicrobial resistance and growing it into a multi-asset early clinical stage...
by Luka Srot | Mar 30, 2021
Joe Larsen is Vice President, Clinical Development at Locus Biosciences where he leads development programs for Locus’s clinical stage assets. Previously, Dr. Larsen was Vice President, Strategic Portfolio Development at Venatorx Pharmaceuticals, a biotechnology...
by mcwebmaster | Mar 7, 2019
Emily Wheeler is Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO). Ms. Wheeler is responsible for working with member companies engaged in antimicrobial research, development, and commercialization, and leads BIO’s antimicrobial...
